Maxwell Biomedical is developing the Spatial Resynchronization Therapy (SRT) System, a non-ablative device that employs ultra-low energy stimulation to restore functional sinus rhythm in patients with atrial fibrillation and heart failure. This technology continuously monitors cardiac activity to prevent AF episodes and improve left atrial function, addressing the increased risks of stroke and heart failure associated with these conditions.
Funding
$9.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Atrial fibrillation (AF) and heart failure (HF) often coexist, exacerbating each other and leading to increased risks of stroke, dementia, HF hospitalization, and mortality. Current treatments for AF, such as ablation, can be invasive and may not be suitable for all patients, particularly those with heart failure.
Solution
Maxwell Biomedical is developing the Spatial Resynchronization Therapy (SRT) System, a non-ablative device designed to restore functional sinus rhythm in patients with both atrial fibrillation and heart failure. The SRT system uses ultra-low energy stimulation to prevent AF episodes and improve left atrial function without damaging heart tissue. By continuously monitoring cardiac activity and applying targeted pacing strategies, the device aims to maintain a steady heartbeat and support positive structural changes in the heart. The system integrates preemptive and postemptive strategies for AF management, along with comprehensive patient monitoring for telehealth management of heart failure.
Target Audience
The primary target audience includes patients with both atrial fibrillation and heart failure, as well as cardiologists and healthcare providers specializing in cardiac care innovation.
Features
- Non-ablative technology using ultra-low energy stimulation to terminate AF and restore left atrial function.
- Continuous monitoring of premature atrial contractions (PACs), ectopic foci, and other indicators to detect early warning signs of AF.
- Algorithm-driven pacing to maintain sinus rhythm and prevent AF episodes.
- Targeted pacing strategy based on recorded AF patterns to restore normal sinus rhythm.
- Left atrial lead placement on the epicardial posterior wall of the left atrium, near AF sources, without entering or puncturing the heart.
- Telehealth capabilities for remote monitoring of AF episodes, ECGs, heart rate, left-atrial pressure, and bioimpedance.